Economic development of the people has improved their lifestyle. But the challenge that has arisen with this lifestyle change is
The term ‘pharmacovigilance’ was coined in the mid 70’s by a group of French pharmacologists and toxicologists to describe the
Introduction A biosimilar product, as defined by USFDA, is “a biological product that is highly similar to and has no
Peer Review is the process of evaluation of manuscripts submitted for scientific publication in journals/books, pre-clinical or clinical study reports,
Osteoporosis is a silent age-related skeletal disease characterized by loss of bone mineral density and microarchitectural deterioration leading to increased
The month of May is commemorated as Cystic Fibrosis Awareness Month. It aims at raising awareness about cystic fibrosis (CF).
Most of us have possibly used it or sprinkled on our skin at some point in our life, ‘Talc’ which
Diagnostics play a very important role in our everyday life, be it for a disease, condition or identification of a
The regulatory authorities have been on fire lately. They are vigilantly sniffing any suspicious and harmful substance in healthcare and
Effective from March 19, 2019, The New Drug and Clinical Trial Rules released by the Ministry of Health and Family
Partner with Turacoz to bring science to life through strategic and evidence- based communication.